About
Therapeutic Vaccines
Areas of Focus
Categories
Biologics & BiopharmaceuticalVaccine
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
190
By Phase
PHASE1: 2
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT05846516Lead Sponsor
A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma
PHASE1Recruiting
94 participants
Started: Mar 13, 2023 · Completed: May 31, 2029
NCT04046445Lead Sponsor
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
PHASE1Active, not recruiting
96 participants
Started: Jul 22, 2019 · Completed: Aug 31, 2025
Locations (1)
Headquarters
Geneva, Switzerland
Map
Loading map...